Tarsus Pharmaceuticals reported a gross margin of 93.03% and a net margin of -12.12% for the quarter ended Jun 2026. These financial ratios cover 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||
| Gross Margin | 94.76% | 107.10% | 93.88% | 96.58% | 96.00% | 100.00% | 79.85% | 90.70% | 94.01% | 92.64% | 93.26% | 92.58% | 93.35% | 93.92% | 93.00% | 92.80% | 94.20% | 93.03% | |||||
| EBT Margin | -1,265.89% | -4,271.01% | -3,680.33% | -35.81% | -136.26% | -933.72% | -2,081.93% | -324.72% | -128.74% | -76.64% | -48.81% | -34.76% | -31.96% | -19.67% | -10.69% | -4.11% | -2.79% | -10.56% | |||||
| EBIT Margin | -1,266.53% | -4,274.56% | -3,621.71% | -34.20% | -150.61% | -998.08% | -2,187.87% | -339.94% | -136.47% | -81.60% | -52.29% | -36.77% | -33.55% | -21.61% | -12.24% | -5.26% | -3.78% | -11.45% | |||||
| EBITDA Margin | -1,266.53% | -4,274.56% | -3,621.71% | -34.20% | -150.61% | -998.08% | -2,187.87% | -339.94% | -136.47% | -81.60% | -52.29% | -36.77% | -33.55% | -21.61% | -12.24% | -5.26% | -3.78% | -11.45% | |||||
| Operating Margin | -1,266.53% | -4,274.56% | -3,621.71% | -34.20% | -150.61% | -998.08% | -2,187.87% | -339.94% | -136.47% | -81.60% | -52.29% | -36.77% | -33.55% | -21.61% | -12.24% | -5.26% | -3.78% | -11.45% | |||||
| Net Margin | -1,238.39% | -4,286.98% | -3,680.52% | -35.81% | -136.26% | -933.72% | -2,081.93% | -324.72% | -128.74% | -76.64% | -48.81% | -34.76% | -31.96% | -19.67% | -10.69% | -4.11% | -4.28% | -12.12% | |||||
| FCF Margin | 538.39% | -3,439.05% | -2,865.86% | -28.68% | -110.01% | -892.40% | -1,749.71% | -300.82% | -137.48% | -37.84% | -18.57% | -33.51% | -27.12% | -29.60% | 13.77% | 8.55% | -18.80% | 32.86% | |||||
| Efficiency | |||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.56M | 3.57M | 3.12M | 2.52M | 2.73M | 2.66M | 3.29M | 3.85M | 4.10M | 4.47M | 4.47M | ||||||||||||
| Assets AverageAssets Avg. | 196.93M | 184.66M | 180.19M | 217.16M | 244.65M | 232.16M | 219.54M | 200.07M | 228.63M | 266.91M | 307.38M | 363.06M | 376.57M | 376.65M | 438.87M | 497.87M | 514.78M | 548.36M | 571.65M | 596.14M | |||
| Invested CapitalInvested Cap. | 166.73M | 168.38M | 240.77M | 221.98M | 212.33M | 197.92M | 172.34M | 243.37M | 226.81M | 305.14M | 323.82M | 309.19M | 296.38M | 414.44M | 404.74M | 407.36M | 415.86M | 421.55M | 419.49M | ||||
| Asset Utilization RatioAsset Util. | 0.29 | 0.31 | 0.13 | 0.08 | 0.07 | 0.11 | 0.13 | 0.06 | 0.06 | 0.07 | 0.14 | 0.23 | 0.34 | 0.49 | 0.53 | 0.59 | 0.71 | 0.82 | 0.94 | 1.02 | |||
| Leverage & Solvency | |||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -61.78 | -9.60 | -36.19 | -21.76 | -36.48 | -40.27 | -47.71 | -44.94 | -38.34 | -15.79 | -10.29 | -10.56 | -11.88 | -9.90 | -6.41 | -3.60 | -2.88 | -9.23 | |||||
| Debt Ratio | 0.11 | 0.08 | 0.08 | 0.09 | 0.12 | 0.13 | 0.11 | 0.11 | 0.09 | 0.19 | 0.19 | 0.19 | 0.14 | 0.15 | 0.14 | 0.13 | 0.12 | 0.12 | |||||
| Times Interest Earned | -61.78 | -9.60 | -36.19 | -21.76 | -36.48 | -40.27 | -47.71 | -44.94 | -38.34 | -15.79 | -10.29 | -10.56 | -11.88 | -9.90 | -6.41 | -3.60 | -2.88 | -9.23 | |||||
| Valuation | |||||||||||||||||||||||
| Price to EarningsP/E | -29.05 | -32.14 | -17.57 | -71.10 | -20.34 | -28.76 | -14.43 | -15.48 | -15.10 | -16.32 | -38.60 | -33.04 | -53.49 | -91.98 | -86.16 | -84.67 | -198.90 | -558.38 | -435.62 | -129.19 | |||
| Price to SalesP/S | 359.75 | 0.00M | 646.54 | 25.46 | 39.18 | 134.75 | 314.41 | 52.98 | 49.69 | 25.33 | 26.11 | 31.98 | 27.54 | 16.66 | 21.25 | 22.97 | 18.62 | 15.66 | |||||
| Price to BookP/B | 2.49 | 2.79 | 2.34 | 1.76 | 2.26 | 2.03 | 1.94 | 3.29 | 2.75 | 3.52 | 4.99 | 4.10 | 5.29 | 9.46 | 6.30 | 5.14 | 7.53 | 10.15 | 8.65 | 7.85 | |||
| Enterprise Value | 262.28M | 293.94M | 173.18M | 143.61M | 230.53M | 174.80M | 135.66M | 307.85M | 341.37M | 465.33M | 1,073.67M | 710.09M | 939.32M | 1,832.05M | 1,749.39M | 1,328.82M | 2,120.84M | 3,067.05M | 2,629.21M | 2,273.81M | |||
| EV to EBIT | -16.70 | -20.34 | -8.87 | -27.49 | -10.06 | -11.61 | -5.44 | -9.38 | -8.34 | -10.47 | -28.49 | -21.32 | -37.33 | -75.02 | -66.57 | -59.90 | -145.97 | -384.53 | -429.47 | -114.22 | |||
| EV to EBITDA | -16.70 | -20.34 | -8.87 | -27.49 | -10.06 | -11.61 | -5.44 | -9.38 | -8.34 | -10.47 | -28.49 | -21.32 | -37.33 | -75.02 | -66.57 | -59.90 | -145.97 | -384.53 | -429.47 | -114.22 | |||
| Market Capitalization | 446.08M | 465.75M | 348.49M | 389.01M | 457.10M | 391.82M | 336.88M | 486.08M | 588.26M | 692.78M | 1,372.19M | 1,033.67M | 1,256.27M | 2,123.43M | 2,157.31M | 1,709.97M | 2,522.68M | 3,484.32M | 3,017.95M | 2,723.50M | |||
| Price to FCFP/FCF | 66.82 | -40.07 | -22.56 | -88.79 | -24.43 | -35.62 | -15.10 | -19.75 | -17.97 | -17.61 | -36.15 | -66.93 | -140.62 | -95.42 | -101.56 | -56.27 | 154.32 | 268.60 | -99.05 | 47.65 | |||
| EV to FCF | 39.29 | -25.29 | -11.21 | -32.78 | -12.32 | -15.89 | -6.08 | -12.51 | -10.43 | -11.83 | -28.28 | -45.98 | -105.14 | -82.32 | -82.36 | -43.73 | 129.74 | 236.44 | -86.29 | 39.78 | |||
| EV to CFO | 36.88 | -24.25 | -11.33 | -33.72 | -12.39 | -16.07 | -6.17 | -12.92 | -10.55 | -11.83 | -28.41 | -49.30 | -108.57 | -82.59 | -84.71 | -45.22 | 116.17 | 158.67 | -106.65 | 37.14 | |||
| Return Ratios | |||||||||||||||||||||||
| Return on Sales [ROS]ROS | -1,266.53% | -4,274.56% | -3,621.71% | -34.20% | -384.42% | -150.61% | -998.08% | -765.92% | -2,187.87% | -339.94% | -136.47% | -81.60% | -52.29% | -36.77% | -33.55% | -21.61% | -12.24% | -5.26% | -3.78% | -11.45% | |||
| Return on Capital Employed [ROCE]ROCE | -4.92% | -7.02% | -25.30% | -26.72% | -26.96% | -28.93% | -33.03% | -51.67% | -55.39% | -62.25% | -58.86% | -50.20% | -45.25% | -40.73% | -30.96% | -24.05% | -21.98% | -17.20% | -11.87% | -11.55% | |||
| Return on Invested Capital [ROIC]ROIC | -25.15% | -26.70% | -26.86% | -28.88% | -33.22% | -51.71% | -12.80% | -12.95% | |||||||||||||||
| Return on Assets [ROA]ROA | -4.65% | -6.59% | -23.54% | -25.40% | -25.45% | -26.45% | -29.57% | -45.41% | -46.95% | -51.02% | -48.27% | -40.83% | -35.26% | -30.11% | -23.44% | -18.44% | -15.74% | -11.70% | -8.05% | -7.87% |